Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

03Apr 2025

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

More
28Mar 2025

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

More

Financial Calendar

09Apr 2025

24th Annual Needham Virtual Healthcare Conference

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.
Youtube